(MedPage Today) -- Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment